 | • レポートコード：MRC2-11QY01793 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は筋肉内免疫グロブリンのグローバル市場について調査・分析したレポートです。種類別（10mLバイアル、2.0mLバイアル）市場規模、用途別（A型肝炎、はしか、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別筋肉内免疫グロブリンの競争状況、市場シェア ・世界の筋肉内免疫グロブリン市場：種類別市場規模 2015年-2020年（10mLバイアル、2.0mLバイアル） ・世界の筋肉内免疫グロブリン市場：種類別市場規模予測 2021年-2026年（10mLバイアル、2.0mLバイアル） ・世界の筋肉内免疫グロブリン市場：用途別市場規模 2015年-2020年（A型肝炎、はしか、その他） ・世界の筋肉内免疫グロブリン市場：用途別市場規模予測 2021年-2026年（A型肝炎、はしか、その他） ・北米の筋肉内免疫グロブリン市場分析：米国、カナダ ・ヨーロッパの筋肉内免疫グロブリン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの筋肉内免疫グロブリン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の筋肉内免疫グロブリン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの筋肉内免疫グロブリン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Grifols Therapeutics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Intramuscular Immune Globulin Market
The global Intramuscular Immune Globulin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Intramuscular Immune Globulin Scope and Market Size
Intramuscular Immune Globulin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intramuscular Immune Globulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Intramuscular Immune Globulin market is segmented into
10mL Vial
2.0mL Vial
Segment by Application, the Intramuscular Immune Globulin market is segmented into
Hepatitis A
Measles
Others
Regional and Country-level Analysis
The Intramuscular Immune Globulin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Intramuscular Immune Globulin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Intramuscular Immune Globulin Market Share Analysis
Intramuscular Immune Globulin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Intramuscular Immune Globulin business, the date to enter into the Intramuscular Immune Globulin market, Intramuscular Immune Globulin product introduction, recent developments, etc.
The major vendors covered:
Grifols Therapeutics
…
1 Study Coverage
1.1 Intramuscular Immune Globulin Product Introduction
1.2 Market Segments
1.3 Key Intramuscular Immune Globulin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Intramuscular Immune Globulin Market Size Growth Rate by Type
1.4.2 10mL Vial
1.4.3 2.0mL Vial
1.5 Market by Application
1.5.1 Global Intramuscular Immune Globulin Market Size Growth Rate by Application
1.5.2 Hepatitis A
1.5.3 Measles
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Intramuscular Immune Globulin Market Size, Estimates and Forecasts
2.1.1 Global Intramuscular Immune Globulin Revenue 2015-2026
2.1.2 Global Intramuscular Immune Globulin Sales 2015-2026
2.2 Global Intramuscular Immune Globulin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Intramuscular Immune Globulin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Intramuscular Immune Globulin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Intramuscular Immune Globulin Competitor Landscape by Players
3.1 Intramuscular Immune Globulin Sales by Manufacturers
3.1.1 Intramuscular Immune Globulin Sales by Manufacturers (2015-2020)
3.1.2 Intramuscular Immune Globulin Sales Market Share by Manufacturers (2015-2020)
3.2 Intramuscular Immune Globulin Revenue by Manufacturers
3.2.1 Intramuscular Immune Globulin Revenue by Manufacturers (2015-2020)
3.2.2 Intramuscular Immune Globulin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Intramuscular Immune Globulin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Intramuscular Immune Globulin Revenue in 2019
3.2.5 Global Intramuscular Immune Globulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Intramuscular Immune Globulin Price by Manufacturers
3.4 Intramuscular Immune Globulin Manufacturing Base Distribution, Product Types
3.4.1 Intramuscular Immune Globulin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intramuscular Immune Globulin Product Type
3.4.3 Date of International Manufacturers Enter into Intramuscular Immune Globulin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Intramuscular Immune Globulin Market Size by Type (2015-2020)
4.1.1 Global Intramuscular Immune Globulin Sales by Type (2015-2020)
4.1.2 Global Intramuscular Immune Globulin Revenue by Type (2015-2020)
4.1.3 Intramuscular Immune Globulin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Intramuscular Immune Globulin Market Size Forecast by Type (2021-2026)
4.2.1 Global Intramuscular Immune Globulin Sales Forecast by Type (2021-2026)
4.2.2 Global Intramuscular Immune Globulin Revenue Forecast by Type (2021-2026)
4.2.3 Intramuscular Immune Globulin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Intramuscular Immune Globulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Intramuscular Immune Globulin Market Size by Application (2015-2020)
5.1.1 Global Intramuscular Immune Globulin Sales by Application (2015-2020)
5.1.2 Global Intramuscular Immune Globulin Revenue by Application (2015-2020)
5.1.3 Intramuscular Immune Globulin Price by Application (2015-2020)
5.2 Intramuscular Immune Globulin Market Size Forecast by Application (2021-2026)
5.2.1 Global Intramuscular Immune Globulin Sales Forecast by Application (2021-2026)
5.2.2 Global Intramuscular Immune Globulin Revenue Forecast by Application (2021-2026)
5.2.3 Global Intramuscular Immune Globulin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Intramuscular Immune Globulin by Country
6.1.1 North America Intramuscular Immune Globulin Sales by Country
6.1.2 North America Intramuscular Immune Globulin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Intramuscular Immune Globulin Market Facts & Figures by Type
6.3 North America Intramuscular Immune Globulin Market Facts & Figures by Application
7 Europe
7.1 Europe Intramuscular Immune Globulin by Country
7.1.1 Europe Intramuscular Immune Globulin Sales by Country
7.1.2 Europe Intramuscular Immune Globulin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Intramuscular Immune Globulin Market Facts & Figures by Type
7.3 Europe Intramuscular Immune Globulin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Intramuscular Immune Globulin by Region
8.1.1 Asia Pacific Intramuscular Immune Globulin Sales by Region
8.1.2 Asia Pacific Intramuscular Immune Globulin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Intramuscular Immune Globulin Market Facts & Figures by Type
8.3 Asia Pacific Intramuscular Immune Globulin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Intramuscular Immune Globulin by Country
9.1.1 Latin America Intramuscular Immune Globulin Sales by Country
9.1.2 Latin America Intramuscular Immune Globulin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Intramuscular Immune Globulin Market Facts & Figures by Type
9.3 Central & South America Intramuscular Immune Globulin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Intramuscular Immune Globulin by Country
10.1.1 Middle East and Africa Intramuscular Immune Globulin Sales by Country
10.1.2 Middle East and Africa Intramuscular Immune Globulin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Intramuscular Immune Globulin Market Facts & Figures by Type
10.3 Middle East and Africa Intramuscular Immune Globulin Market Facts & Figures by Application
11 Company Profiles
11.1 Grifols Therapeutics
11.1.1 Grifols Therapeutics Corporation Information
11.1.2 Grifols Therapeutics Description and Business Overview
11.1.3 Grifols Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Grifols Therapeutics Intramuscular Immune Globulin Products Offered
11.1.5 Grifols Therapeutics Related Developments
11.1 Grifols Therapeutics
11.1.1 Grifols Therapeutics Corporation Information
11.1.2 Grifols Therapeutics Description and Business Overview
11.1.3 Grifols Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Grifols Therapeutics Intramuscular Immune Globulin Products Offered
11.1.5 Grifols Therapeutics Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Intramuscular Immune Globulin Market Estimates and Projections by Region
12.1.1 Global Intramuscular Immune Globulin Sales Forecast by Regions 2021-2026
12.1.2 Global Intramuscular Immune Globulin Revenue Forecast by Regions 2021-2026
12.2 North America Intramuscular Immune Globulin Market Size Forecast (2021-2026)
12.2.1 North America: Intramuscular Immune Globulin Sales Forecast (2021-2026)
12.2.2 North America: Intramuscular Immune Globulin Revenue Forecast (2021-2026)
12.2.3 North America: Intramuscular Immune Globulin Market Size Forecast by Country (2021-2026)
12.3 Europe Intramuscular Immune Globulin Market Size Forecast (2021-2026)
12.3.1 Europe: Intramuscular Immune Globulin Sales Forecast (2021-2026)
12.3.2 Europe: Intramuscular Immune Globulin Revenue Forecast (2021-2026)
12.3.3 Europe: Intramuscular Immune Globulin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Intramuscular Immune Globulin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Intramuscular Immune Globulin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Intramuscular Immune Globulin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Intramuscular Immune Globulin Market Size Forecast by Region (2021-2026)
12.5 Latin America Intramuscular Immune Globulin Market Size Forecast (2021-2026)
12.5.1 Latin America: Intramuscular Immune Globulin Sales Forecast (2021-2026)
12.5.2 Latin America: Intramuscular Immune Globulin Revenue Forecast (2021-2026)
12.5.3 Latin America: Intramuscular Immune Globulin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Intramuscular Immune Globulin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Intramuscular Immune Globulin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Intramuscular Immune Globulin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Intramuscular Immune Globulin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Intramuscular Immune Globulin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Intramuscular Immune Globulin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Intramuscular Immune Globulin Market Segments
Table 2. Ranking of Global Top Intramuscular Immune Globulin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Intramuscular Immune Globulin Market Size Growth Rate by Type 2020-2026 (Kiloton) & (US$ Million)
Table 4. Major Manufacturers of 10mL Vial
Table 5. Major Manufacturers of 2.0mL Vial
Table 6. Global Intramuscular Immune Globulin Market Size Growth Rate by Application 2020-2026 (Kiloton)
Table 7. Global Intramuscular Immune Globulin Market Size by Region (Kiloton) & (US$ Million): 2020 VS 2026
Table 8. Global Intramuscular Immune Globulin Sales by Regions 2015-2020 (Kiloton)
Table 9. Global Intramuscular Immune Globulin Sales Market Share by Regions (2015-2020)
Table 10. Global Intramuscular Immune Globulin Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Intramuscular Immune Globulin Sales by Manufacturers (2015-2020) (Kiloton)
Table 12. Global Intramuscular Immune Globulin Sales Share by Manufacturers (2015-2020)
Table 13. Global Intramuscular Immune Globulin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Intramuscular Immune Globulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intramuscular Immune Globulin as of 2019)
Table 15. Intramuscular Immune Globulin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Intramuscular Immune Globulin Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Intramuscular Immune Globulin Price (2015-2020) (US$/Ton)
Table 18. Intramuscular Immune Globulin Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Intramuscular Immune Globulin Product Type
Table 20. Date of International Manufacturers Enter into Intramuscular Immune Globulin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Intramuscular Immune Globulin Sales by Type (2015-2020) (Kiloton)
Table 23. Global Intramuscular Immune Globulin Sales Share by Type (2015-2020)
Table 24. Global Intramuscular Immune Globulin Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Intramuscular Immune Globulin Revenue Share by Type (2015-2020)
Table 26. Intramuscular Immune Globulin Average Selling Price (ASP) by Type 2015-2020 (US$/Ton)
Table 27. Global Intramuscular Immune Globulin Sales by Application (2015-2020) (Kiloton)
Table 28. Global Intramuscular Immune Globulin Sales Share by Application (2015-2020)
Table 29. North America Intramuscular Immune Globulin Sales by Country (2015-2020) (Kiloton)
Table 30. North America Intramuscular Immune Globulin Sales Market Share by Country (2015-2020)
Table 31. North America Intramuscular Immune Globulin Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Intramuscular Immune Globulin Revenue Market Share by Country (2015-2020)
Table 33. North America Intramuscular Immune Globulin Sales by Type (2015-2020) (Kiloton)
Table 34. North America Intramuscular Immune Globulin Sales Market Share by Type (2015-2020)
Table 35. North America Intramuscular Immune Globulin Sales by Application (2015-2020) (Kiloton)
Table 36. North America Intramuscular Immune Globulin Sales Market Share by Application (2015-2020)
Table 37. Europe Intramuscular Immune Globulin Sales by Country (2015-2020) (Kiloton)
Table 38. Europe Intramuscular Immune Globulin Sales Market Share by Country (2015-2020)
Table 39. Europe Intramuscular Immune Globulin Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Intramuscular Immune Globulin Revenue Market Share by Country (2015-2020)
Table 41. Europe Intramuscular Immune Globulin Sales by Type (2015-2020) (Kiloton)
Table 42. Europe Intramuscular Immune Globulin Sales Market Share by Type (2015-2020)
Table 43. Europe Intramuscular Immune Globulin Sales by Application (2015-2020) (Kiloton)
Table 44. Europe Intramuscular Immune Globulin Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Intramuscular Immune Globulin Sales by Region (2015-2020) (Kiloton)
Table 46. Asia Pacific Intramuscular Immune Globulin Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Intramuscular Immune Globulin Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Intramuscular Immune Globulin Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Intramuscular Immune Globulin Sales by Type (2015-2020) (Kiloton)
Table 50. Asia Pacific Intramuscular Immune Globulin Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Intramuscular Immune Globulin Sales by Application (2015-2020) (Kiloton)
Table 52. Asia Pacific Intramuscular Immune Globulin Sales Market Share by Application (2015-2020)
Table 53. Latin America Intramuscular Immune Globulin Sales by Country (2015-2020) (Kiloton)
Table 54. Latin America Intramuscular Immune Globulin Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Intramuscular Immune Globulin Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Intramuscular Immune Globulin Revenue Market Share by Country (2015-2020)
Table 57. Latin America Intramuscular Immune Globulin Sales by Type (2015-2020) (Kiloton)
Table 58. Latin America Intramuscular Immune Globulin Sales Market Share by Type (2015-2020)
Table 59. Latin America Intramuscular Immune Globulin Sales by Application (2015-2020) (Kiloton)
Table 60. Latin America Intramuscular Immune Globulin Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Intramuscular Immune Globulin Sales by Country (2015-2020) (Kiloton)
Table 62. Middle East and Africa Intramuscular Immune Globulin Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Intramuscular Immune Globulin Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Intramuscular Immune Globulin Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Intramuscular Immune Globulin Sales by Type (2015-2020) (Kiloton)
Table 66. Middle East and Africa Intramuscular Immune Globulin Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Intramuscular Immune Globulin Sales by Application (2015-2020) (Kiloton)
Table 68. Middle East and Africa Intramuscular Immune Globulin Sales Market Share by Application (2015-2020)
Table 69. Grifols Therapeutics Corporation Information
Table 70. Grifols Therapeutics Description and Major Businesses
Table 71. Grifols Therapeutics Intramuscular Immune Globulin Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 72. Grifols Therapeutics Product
Table 73. Grifols Therapeutics Recent Development
Table 74. Global Intramuscular Immune Globulin Sales Forecast by Regions (2021-2026) (Kiloton)
Table 75. Global Intramuscular Immune Globulin Sales Market Share Forecast by Regions (2021-2026)
Table 76. Global Intramuscular Immune Globulin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 77. Global Intramuscular Immune Globulin Revenue Market Share Forecast by Regions (2021-2026)
Table 78. North America: Intramuscular Immune Globulin Sales Forecast by Country (2021-2026) (Kiloton)
Table 79. North America: Intramuscular Immune Globulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 80. Europe: Intramuscular Immune Globulin Sales Forecast by Country (2021-2026) (Kiloton)
Table 81. Europe: Intramuscular Immune Globulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 82. Asia Pacific: Intramuscular Immune Globulin Sales Forecast by Region (2021-2026) (Kiloton)
Table 83. Asia Pacific: Intramuscular Immune Globulin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 84. Latin America: Intramuscular Immune Globulin Sales Forecast by Country (2021-2026) (Kiloton)
Table 85. Latin America: Intramuscular Immune Globulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 86. Middle East and Africa: Intramuscular Immune Globulin Sales Forecast by Country (2021-2026) (Kiloton)
Table 87. Middle East and Africa: Intramuscular Immune Globulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 89. Key Challenges
Table 90. Market Risks
Table 91. Main Points Interviewed from Key Intramuscular Immune Globulin Players
Table 92. Intramuscular Immune Globulin Customers List
Table 93. Intramuscular Immune Globulin Distributors List
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Intramuscular Immune Globulin Product Picture
Figure 2. Global Intramuscular Immune Globulin Sales Market Share by Type in 2020 & 2026
Figure 3. 10mL Vial Product Picture
Figure 4. 2.0mL Vial Product Picture
Figure 5. Global Intramuscular Immune Globulin Sales Market Share by Application in 2020 & 2026
Figure 6. Hepatitis A
Figure 7. Measles
Figure 8. Others
Figure 9. Intramuscular Immune Globulin Report Years Considered
Figure 10. Global Intramuscular Immune Globulin Market Size 2015-2026 (US$ Million)
Figure 11. Global Intramuscular Immune Globulin Sales 2015-2026 (Kiloton)
Figure 12. Global Intramuscular Immune Globulin Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Intramuscular Immune Globulin Sales Market Share by Region (2015-2020)
Figure 14. Global Intramuscular Immune Globulin Sales Market Share by Region in 2019
Figure 15. Global Intramuscular Immune Globulin Revenue Market Share by Region (2015-2020)
Figure 16. Global Intramuscular Immune Globulin Revenue Market Share by Region in 2019
Figure 17. Global Intramuscular Immune Globulin Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Intramuscular Immune Globulin Revenue in 2019
Figure 19. Intramuscular Immune Globulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Intramuscular Immune Globulin Sales Market Share by Type (2015-2020)
Figure 21. Global Intramuscular Immune Globulin Sales Market Share by Type in 2019
Figure 22. Global Intramuscular Immune Globulin Revenue Market Share by Type (2015-2020)
Figure 23. Global Intramuscular Immune Globulin Revenue Market Share by Type in 2019
Figure 24. Global Intramuscular Immune Globulin Market Share by Price Range (2015-2020)
Figure 25. Global Intramuscular Immune Globulin Sales Market Share by Application (2015-2020)
Figure 26. Global Intramuscular Immune Globulin Sales Market Share by Application in 2019
Figure 27. Global Intramuscular Immune Globulin Revenue Market Share by Application (2015-2020)
Figure 28. Global Intramuscular Immune Globulin Revenue Market Share by Application in 2019
Figure 29. North America Intramuscular Immune Globulin Sales Growth Rate 2015-2020 (Kiloton)
Figure 30. North America Intramuscular Immune Globulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Intramuscular Immune Globulin Sales Market Share by Country in 2019
Figure 32. North America Intramuscular Immune Globulin Revenue Market Share by Country in 2019
Figure 33. U.S. Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 34. U.S. Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 36. Canada Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Intramuscular Immune Globulin Market Share by Type in 2019
Figure 38. North America Intramuscular Immune Globulin Market Share by Application in 2019
Figure 39. Europe Intramuscular Immune Globulin Sales Growth Rate 2015-2020 (Kiloton)
Figure 40. Europe Intramuscular Immune Globulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Intramuscular Immune Globulin Sales Market Share by Country in 2019
Figure 42. Europe Intramuscular Immune Globulin Revenue Market Share by Country in 2019
Figure 43. Germany Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 44. Germany Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 46. France Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 48. U.K. Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 50. Italy Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 52. Russia Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Intramuscular Immune Globulin Market Share by Type in 2019
Figure 54. Europe Intramuscular Immune Globulin Market Share by Application in 2019
Figure 55. Asia Pacific Intramuscular Immune Globulin Sales Growth Rate 2015-2020 (Kiloton)
Figure 56. Asia Pacific Intramuscular Immune Globulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Intramuscular Immune Globulin Sales Market Share by Region in 2019
Figure 58. Asia Pacific Intramuscular Immune Globulin Revenue Market Share by Region in 2019
Figure 59. China Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 60. China Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 62. Japan Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 64. South Korea Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 66. India Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 68. Australia Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 70. Taiwan Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 72. Indonesia Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 74. Thailand Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 76. Malaysia Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 78. Philippines Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 80. Vietnam Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Intramuscular Immune Globulin Market Share by Type in 2019
Figure 82. Asia Pacific Intramuscular Immune Globulin Market Share by Application in 2019
Figure 83. Latin America Intramuscular Immune Globulin Sales Growth Rate 2015-2020 (Kiloton)
Figure 84. Latin America Intramuscular Immune Globulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Intramuscular Immune Globulin Sales Market Share by Country in 2019
Figure 86. Latin America Intramuscular Immune Globulin Revenue Market Share by Country in 2019
Figure 87. Mexico Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 88. Mexico Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 90. Brazil Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 92. Argentina Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Intramuscular Immune Globulin Market Share by Type in 2019
Figure 94. Latin America Intramuscular Immune Globulin Market Share by Application in 2019
Figure 95. Middle East and Africa Intramuscular Immune Globulin Sales Growth Rate 2015-2020 (Kiloton)
Figure 96. Middle East and Africa Intramuscular Immune Globulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Intramuscular Immune Globulin Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Intramuscular Immune Globulin Revenue Market Share by Country in 2019
Figure 99. Turkey Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 100. Turkey Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 102. Saudi Arabia Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. UAE Intramuscular Immune Globulin Sales Growth Rate (2015-2020) (Kiloton)
Figure 104. UAE Intramuscular Immune Globulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Intramuscular Immune Globulin Market Share by Type in 2019
Figure 106. Middle East and Africa Intramuscular Immune Globulin Market Share by Application in 2019
Figure 107. North America Intramuscular Immune Globulin Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 108. North America Intramuscular Immune Globulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Intramuscular Immune Globulin Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 110. Europe Intramuscular Immune Globulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Intramuscular Immune Globulin Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 112. Asia Pacific Intramuscular Immune Globulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Intramuscular Immune Globulin Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 114. Latin America Intramuscular Immune Globulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Intramuscular Immune Globulin Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 116. Middle East and Africa Intramuscular Immune Globulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
動物由来免疫グロブリンの世界市場（～2026年） Market Analysis and Insights: Global Animal-derived Immune Globulin Market The global Animal-derived Immune Globulin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Animal-derived Immune Globulin Scope and Market Size …- 免疫レパートリーシーケンスの世界市場（～2026年） Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portr…
- 免疫介在性炎症性疾患治療の世界市場（～2026年） Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune respon…
- 免疫システムサプリメントの世界市場（～2026年） Market Analysis and Insights: Global Immune System Supplements Market The global Immune System Supplements market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
- 免疫BCGの世界市場（～2026年） Market Analysis and Insights: Global Immune BCG Market The global Immune BCG market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Immune BCG Scope and Market Size Immune BCG market is segmented by Type, and by Application. …